TGA Approves AKYNZEO® (netupitant/palonosetron) for the Prevention of Chemotherapy-Induced Nausea and Vomiting (CINV)

20 May 2015

Cerbios has been rewarded at Swiss Venture Club Prix 2015 based on its continued Innovation and Sustainability

19 May 2015

Helsinn Group Signs Exclusive Agreement with Mundipharma for Distribution and Licence of Anamorelin in China, Hong Kong and Macao

27 March 2015

Improved Bioavailability through cGMP super critical fluid atomization

16 March 2015

SFI Awarded Prestigious ABC’s Tyler Award Given Global Research Effort

12 March 2015

Helsinn Group signs exclusive agreements with Mundipharma for distribution and licence of anamorelin in Brazil and across key markets in the Middle East and North Africa

11 February 2015

Helsinn Group signs exclusive agreement with Mundipharma for distribution and licensing of Netupitant/Palonosetron (nepa) in Brazil

10 February 2015

Helsinn and Zealand announce the advance of elsiglutide into Phase IIB development for the prevention of chemotherapyinduced diarrhea

6 February 2015

Helsinn Group grants stendhal international exclusive rights to the distribution and marketing of Netupitant-Palonosetron (nepa) in multiple countries of Latin America

3 February 2015

Helsinn awards scholarships for advanced synthesis

1 December 2014